Annual Non Current Assets
$1.83 B
-$160.75 M-8.09%
01 December 2023
Summary:
Sinovac Biotech annual long term assets is currently $1.83 billion, with the most recent change of -$160.75 million (-8.09%) on 01 December 2023. During the last 3 years, it has risen by +$1.49 billion (+435.85%). SVA annual non current assets is now -8.09% below its all-time high of $1.99 billion, reached on 31 December 2022.SVA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$1.75 B
-$78.76 M-4.31%
01 June 2024
Summary:
Sinovac Biotech quarterly long term assets is currently $1.75 billion, with the most recent change of -$78.76 million (-4.31%) on 01 June 2024. Over the past year, it has dropped by -$78.76 million (-4.31%). SVA quarterly non current assets is now -12.05% below its all-time high of $1.99 billion, reached on 31 December 2022.SVA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -4.3% |
| 3 y3 years | +435.9% | +86.3% |
| 5 y5 years | +2034.7% | +1697.4% |
SVA Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.1% | +435.9% | -12.1% | +86.3% |
| 5 y | 5 years | -8.1% | +2034.7% | -12.1% | +1697.4% |
| alltime | all time | -8.1% | -12.1% | >+9999.0% |
Sinovac Biotech Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $1.75 B(-4.3%) |
| Dec 2023 | $11.83 B(-2.4%) | $1.83 B(-6.6%) |
| June 2023 | - | $1.96 B(-1.6%) |
| Dec 2022 | $12.13 B(-18.7%) | $1.99 B(+1.9%) |
| June 2022 | - | $1.95 B(+6.4%) |
| Dec 2021 | $14.92 B(+855.9%) | $1.83 B(+95.3%) |
| June 2021 | - | $938.80 M(+175.3%) |
| Dec 2020 | $1.56 B(+346.3%) | $341.03 M(+45.9%) |
| Sept 2020 | - | $233.78 M(+22.2%) |
| June 2020 | - | $191.36 M(+84.1%) |
| Mar 2020 | - | $103.97 M(+1.2%) |
| Dec 2019 | $349.61 M(+23.0%) | $102.69 M(+5.6%) |
| Sept 2019 | - | $97.29 M(-2.7%) |
| June 2019 | - | $100.04 M(+1.4%) |
| Mar 2019 | - | $98.63 M(+15.2%) |
| Dec 2018 | $284.18 M(+39.4%) | $85.61 M(-9.5%) |
| June 2018 | - | $94.61 M(-0.8%) |
| Dec 2017 | $203.89 M(+55.9%) | $95.33 M(+14.8%) |
| June 2017 | - | $83.02 M(+3.0%) |
| Dec 2016 | $130.75 M(+1.8%) | $80.61 M(+3.6%) |
| Sept 2016 | - | $77.78 M(+4.3%) |
| June 2016 | - | $74.53 M(-2.4%) |
| Mar 2016 | - | $76.33 M(+2.6%) |
| Dec 2015 | $128.49 M(-17.0%) | $74.43 M(-6.9%) |
| Sept 2015 | - | $79.95 M(-3.4%) |
| June 2015 | - | $82.76 M(-1.1%) |
| Mar 2015 | - | $83.68 M(-0.1%) |
| Dec 2014 | $154.80 M(-1.6%) | $83.73 M(-1.5%) |
| Sept 2014 | - | $84.99 M(+2.2%) |
| June 2014 | - | $83.18 M(+2.0%) |
| Mar 2014 | - | $81.53 M(-2.3%) |
| Dec 2013 | $157.25 M(+24.5%) | $83.44 M(+3.1%) |
| Sept 2013 | - | $80.91 M(-1.0%) |
| June 2013 | - | $81.76 M(-0.6%) |
| Mar 2013 | - | $82.27 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $126.28 M(-4.4%) | $82.48 M(-5.9%) |
| Sept 2012 | - | $87.67 M(+0.4%) |
| June 2012 | - | $87.36 M(+2.4%) |
| Mar 2012 | - | $85.33 M(+1.7%) |
| Dec 2011 | $132.04 M(-10.4%) | $83.87 M(+9.4%) |
| Sept 2011 | - | $76.65 M(+5.7%) |
| June 2011 | - | $72.50 M(+5.3%) |
| Mar 2011 | - | $68.85 M(+2.7%) |
| Dec 2010 | $147.29 M(+23.5%) | $67.06 M(+4.5%) |
| Sept 2010 | - | $64.17 M(+20.1%) |
| June 2010 | - | $53.44 M(-4.4%) |
| Mar 2010 | - | $55.92 M(+113.7%) |
| Dec 2009 | $119.31 M(+91.6%) | $26.16 M(+1.2%) |
| Sept 2009 | - | $25.87 M(+1.0%) |
| June 2009 | - | $25.60 M(+8.5%) |
| Mar 2009 | - | $23.60 M(+12.8%) |
| Dec 2008 | $62.28 M(+58.9%) | $20.92 M(-4.3%) |
| Sept 2008 | - | $21.87 M(+0.2%) |
| June 2008 | - | $21.82 M(+3.5%) |
| Mar 2008 | - | $21.07 M(+15.4%) |
| Dec 2007 | $39.18 M(+80.2%) | $18.27 M(+6.7%) |
| Sept 2007 | - | $17.12 M(+12.9%) |
| June 2007 | - | $15.16 M(-0.7%) |
| Dec 2006 | $21.74 M(+33.6%) | $15.27 M(+2.1%) |
| June 2006 | - | $14.96 M(-0.4%) |
| Dec 2005 | $16.27 M(+92.1%) | $15.03 M(-6.2%) |
| June 2005 | - | $16.02 M(+14.8%) |
| Dec 2004 | $8.47 M(+114.3%) | $13.95 M(-6.1%) |
| Sept 2004 | - | $14.86 M(+5.9%) |
| June 2004 | - | $14.03 M(+28.2%) |
| Dec 2003 | $3.95 M(+2275.3%) | $10.95 M |
| Apr 2002 | $166.40 K(+0.5%) | - |
| Apr 2001 | $165.60 K(-1.8%) | - |
| Apr 2000 | $168.60 K(+403.3%) | - |
| Apr 1999 | $33.50 K | - |
FAQ
- What is Sinovac Biotech annual long term assets?
- What is the all time high annual non current assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly long term assets?
- What is the all time high quarterly non current assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly non current assets year-on-year change?
What is Sinovac Biotech annual long term assets?
The current annual non current assets of SVA is $1.83 B
What is the all time high annual non current assets for Sinovac Biotech?
Sinovac Biotech all-time high annual long term assets is $1.99 B
What is Sinovac Biotech quarterly long term assets?
The current quarterly non current assets of SVA is $1.75 B
What is the all time high quarterly non current assets for Sinovac Biotech?
Sinovac Biotech all-time high quarterly long term assets is $1.99 B
What is Sinovac Biotech quarterly non current assets year-on-year change?
Over the past year, SVA quarterly long term assets has changed by -$78.76 M (-4.31%)